Reserved for Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.

50% off the $29.99 Customized Fix Kit. Use at checkout:

SUTROBIO50

⚡ This is your brand? Claim your page FREE and bring it to life on AI search.

Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.

Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.

Unclaimed

AEO Score: 4/10

Crawled 1 times by AI engines

Apple Intelligence

sutrobio.com

Share

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company. just got measured.

4/10 means Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company. is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.

Sutro Biopharma, Inc. is a public biotechnology company headquartered in South San Francisco, California focused on clinical stage drug discovery, development and manufacturing company. Using its integrated cell-free protein synthesis platform, XpressCF, to create a variety of protein therapeutics for cancer and autoimmune disorders. It focuses to design therapeutics using potent modalities, including cytokine based immune-oncology (I/O) therapeutics, antibody-drug conjugates (ADCs) and bispecific antibodies that are directed primarily against clinically validated targets. Its product candidates include STRO-001 and STRO-002. STRO-001 is an ADC directed against the cancer target CD74, for patients with multiple myeloma and non-Hodgkin lymphoma (NHL). STRO-002 is an ADC directed against fol

Key Topics

Patients are Sutro’spassion and purpose.
Next Generation Cancer Therapeutics
Science designed to deliver ENDLESS OPPORTUNITY
Enabling a future where more is POSSIBLE.
INVESTOR RESOURCES
NASDAQ: STRO

Details

Industry: biotechnology

Employees: 201-500

Founded: 2003

sutrobio.com

AI Visibility Breakdown

1

Structured Data

5

Content Structure

6

Entity Clarity

4

E-E-A-T Signals

6

Technical AEO

4

AI Discoverability

Is this your brand?

Claim free. You'll see:

Your full 6-category score breakdown

Exact fixes: robots.txt, schema, llms.txt

AI bot crawls from ChatGPT, Claude, Perplexity, Gemini

Personal 50% off code at checkout

Already have an account? Sign in

Picked for Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.: Tech & Electronics

Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?

Tech buyers are the most research-intensive shoppers on the internet.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company..

Source & Attribution

Scored by Engagemii on July 3, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/sutrobio

Cite this score: Engagemii (2026). "AEO Score for Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.." Retrieved from https://engagemii.com/aeo/brands/sutrobio

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - AI Brand Discovery and AEO Platform